“Drug companies know that consumers are now a key element in creating demand even though they still saturate the physicians with detailing and journal ads.”

Bob Ehrlich, CEO of consulting firm DTC Perspectives, on direct-to-consumer pharmaceutical ads. Read more from FiercePharma.